Position in VRTX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$63,812,914
+$7,009,455 QoQ
Shares Held
128,466
+1.0% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#155
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KBC Group NV holds $308,329,109 across 107 Biotechnology names. VRTX ranks #2 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
179,508 | $111,930,417 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
128,466 | $63,812,914 | |
| 3 | INCY |
Incyte Corp
|
270,882 | $30,707,183 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
98,265 | $23,678,916 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
91,584 | $7,963,228 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
129,010 | $7,787,043 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
127,194 | $7,278,040 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
116,847 | $6,372,835 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,812,914 | 128,466 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $56,803,459 | 127,208 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $63,978,162 | 141,120 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $52,323,886 | 133,602 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $59,062,457 | 132,665 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $57,841,449 | 119,305 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $48,094,057 | 119,429 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $44,985,792 | 96,727 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $40,798,326 | 87,042 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $34,348,717 | 82,172 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $41,207,377 | 101,274 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $34,913,095 | 100,400 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $76,321,536 | 216,878 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $60,518,015 | 192,078 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $73,444,550 | 254,327 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $73,535,920 | 253,975 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $81,712,336 | 289,976 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $72,664,225 | 278,439 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $128,521,778 | 585,254 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $50,818,766 | 280,163 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $59,711,917 | 296,146 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $54,370,178 | 253,014 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $57,807,818 | 244,596 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $40,333,081 | 148,218 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $35,490,107 | 122,249 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $23,614,157 | 99,240 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||